Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor by Koushiro Ohtsubo, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Akihiro Nishiyama, Kaname Yamashita, Seiji Yano, Fumihito Toshima, Dai Inoue, Toshifumi Gabata, Hiroko Ikeda, Atsushi Watanabe, Kenji Notohara, Takao Fujisawa, Takao Fujisawa, Takao Fujisawa, Yoshiaki Nakamura, Yoshiaki Nakamura, Yoshiaki Nakamura, Takayuki Yoshino, Takayuki Yoshino, Takayuki Yoshino, Kunio Miyake, Kazuhiro Miwa, Shinji Takeuchi

Get full text

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer by Akinori Sasaki, Kenichi Harano, Takahiro Kogawa, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Hirofumi Mukai, Takayuki Yoshino, Toru Mukohara

Get full text

Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture by Hiroki Hagimoto, Takeshi Sano, Soki Kashima, Takayuki Yoshino, Takayuki Goto, Atsuro Sawada, Shusuke Akamatsu, Toshinari Yamasaki, Masakazu Fujimoto, Yoichiro Kajita, Takashi Kobayashi, Osamu Ogawa

Get full text

SpatialKNifeY (SKNY): Extending from spatial domain to surrounding area to identify microenvironment features with single-cell spatial omics data. by Shunsuke A Sakai, Ryosuke Nomura, Satoi Nagasawa, SungGi Chi, Ayako Suzuki, Yutaka Suzuki, Mitsuho Imai, Yoshiaki Nakamura, Takayuki Yoshino, Shumpei Ishikawa, Katsuya Tsuchihara, Shun-Ichiro Kageyama, Riu Yamashita

Get full text

Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomark... by Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina, Elena Elez, Javier Rodriguez, Ian Chau, Maria Di Bartolomeo, Hisato Kawakami, Fumitaka Suto, Makito Koga, Koichiro Inaki, Yusuke Kuwahara, Issey Takehara, Daniel Barrios, Kojiro Kobayashi, Axel Grothey, Takayuki Yoshino

Get full text

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical tr... by Takayuki Yoshino, Josep Tabernero, Jin Yao, Amit Mahipal, Eric Chen, Heinz-Josef Lenz, Aparna Parikh, Timothy Larson, Dustin Deming, David R Spigel, Allen L Cohn, Mark Kochenderfer, Elena Elez, Spencer H Shao, Regan Holdridge, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell

Get full text

HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer by Chiara M. L. Loeffler, Hideaki Bando, Srividhya Sainath, Hannah Sophie Muti, Xiaofeng Jiang, Marko van Treeck, Nic Gabriel Reitsam, Zunamys I. Carrero, Asier Rabasco Meneghetti, Tomomi Nishikawa, Toshihiro Misumi, Saori Mishima, Daisuke Kotani, Hiroya Taniguchi, Ichiro Takemasa, Takeshi Kato, Eiji Oki, Yuan Tanwei, Wankhede Durgesh, Sebastian Foersch, Hermann Brenner, Michael Hoffmeister, Yoshiaki Nakamura, Takayuki Yoshino, Jakob Nikolas Kather

Get full text

Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial by Yuichiro Tsukada, MD, PhD, Norio Saito, MD, PhD, Yuji Nishizawa, MD, PhD, Riki Ohno, MD, PhD, Fumihiko Fujita, MD, PhD, Keiji Koda, MD, PhD, Masayuki Ohue, MD, PhD, Eiji Shinto, MD, PhD, Akihiko Murata, MD, PhD, Yoshikazu Koide, MD, PhD, Koji Ikeda, MD, PhD, Hideaki Bando, MD, PhD, Motoko Suzuki, Toshihiro Misumi, PhD, Takayuki Yoshino, MD, PhD, Masaaki Ito, MD, PhD

Get full text